Cinctive Capital Management’s Avidity Biosciences RNAM Stock Holding History

Cinctive Capital Management’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-50,000	Closed	-$3.61M	–	490
2025 Q4	$3.61M	Buy	50,000 +19,923	+66%	+$1.29M	0.2%	145
2025 Q3	$1.31M	Buy	+30,077	New	+$1.22M	0.06%	282
2025 Q1	–	Sell	-43,699	Closed	-$1.27M	–	437
2024 Q4	$1.27M	Sell	43,699 -3,855	-8%	-$161K	0.06%	268
2024 Q3	$2.18M	Sell	47,554 -35,808	-43%	-$1.55M	0.12%	224
2024 Q2	$3.41M	Buy	+83,362	New	+$2.39M	0.16%	188

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Cinctive Capital Management's RNAM Position: Q1 2026 in Review

Cinctive Capital Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 50,000 shares — an estimated $3.61M sold.

Cinctive Capital Management first reported a position in RNAM in Q2 2024 and held it in 5 quarters. The position peaked at $3.61M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Cinctive Capital Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Cinctive Capital Management sold 50,000 Avidity Biosciences shares in Q1 2026, an estimated $3.61M.
Cinctive Capital Management first reported a position in Avidity Biosciences in Q2 2024 and held it in 5 quarters.
Cinctive Capital Management's Avidity Biosciences position peaked at $3.61M in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Cinctive Capital Management's 13F filing for Q1 2026, filed 15 May 2026.